A visual representation of a phase 2 randomized trial of mezagitamab in primary immune thrombocytopenia.
Available therapies for immune thrombocytopenia are ineffective in some patients. Research evaluating mezagitamab is summarized in a new Quick Take video. nej.md/4snStLF
#Hematology #Immunology
Fortrea's "Hope in a Dose" cell and gene therapy podcast is now available on your favorite podcast platform. Check it out on Amazon Music, Apple Podcasts, Audible, Buzzsprout, I❤️Radio, Pandora, Spotify, and YouTube Podcasts. Just search for "Fortrea."
#clinicaltrials #podcast #cgt
Liebe Männer, verstecken wir uns nicht hinter dem Satz „Not all men“.
Stärken wir stattdessen unseren Kolleginnen den Rücken. Holen wir Frauen auf die Podien und in die Gremien dieser Welt. Und tragen wir auch im Alltag unseren Teil mit. (vdb)
#Frauentag2026
This International Women’s Day, our Fortrea colleagues around the world came together to Embrace You, Empower Her. 🌸
Thank you to everyone who participated and helped make this global moment possible. 💜
#InternationalWomensDay #IWD2026 #InclusionInAction
Love my #ASH25 bag @ash.hematology.org
#fightforhematology #vacations
Practice changing plenary #ASH25‼️
Iron is hypothesized to feed infxn & IV iron often avoided in that setting.
>85k people hospitalized w/5 most common bacterial infxns, compared those who recvd IV iron to those who did not.
🩸greater hemoglobin increase
🩸lower mortality at 14 & 90 days
@ash.hematology.org kicking off ASH2025 with an inspiring talk about VWFs role in angiogenesis @mlewandowskamd.bsky.social
#PrecisionMedicine is moving fast. See what is next at #ASH25 as Dr. Sophie Zaaijer shows how genetic diversity drives stronger discovery. Register now: https://ow.ly/Mekn50Xs1oc
#HemeSky #MedSky #ASHinaFlash
It’s Friday, I’m in love.
Weekend long read, anyone? The @fwf-at.bsky.social features IMBA Scientific Director Elly Tanaka in a new article that lays out how she pioneered research in regeneration biology, bringing axolotls as a model organism to the molecular era.
Another amazing opportunity to engage with the fabulous rare diseases community comes to a close. encouraging meeting stakeholders working together bringing innovative treatments to people living with rare conditions ✨the future is bright
@fortrea.bsky.social @fortreatrials.bsky.social
Last day starting with an inspiring panel discussion about how new technologies can be leveraged for smarter decision making in #raredisease #drugdevelopment #access #innovation #WODCEU25 #AI
#WODC2025 inspiring key note about Europe‘s life science strategy ✨
#innovation #research #takeda #norgine #europeancommission #eurordis
Bridging the gap #WODC25 #raredisease #ERDERA
Inspiring panel discussions
Thrilled to be #WODC25 starting with an important topic: innovative methodologies to accelerate rare diseases drug development #ERDERA #raredisease #patientcentricity
New @nejm.org
One-shot gene therapy for a type of congenital deafness enabled some children to hear for the first time, and 3 of 12 kids achieved normal hearing
www.nejm.org/doi/full/10.1056/NEJMoa2400521
🤖🩸 #ArtificialIntelligence in everyday clinical practice: A study by #MedUniVienna shows that language models sometimes provide better answers than experts when it comes to questions about #venousthromboembolism. ⬇️
📰 Results in @jthjournal.bsky.social
🚀 AI vs. Thrombosis Experts: Who performs better?
New study shows: AI models deliver patient education answers that are often rated better than experts — and perform similar in complex clinical cases.
@nikola-vladic.bsky.social @jeanconnorsmd.bsky.social @jthjournal.bsky.social
We just learned about a 3rd dimension of how Covid can affect our arteries.
erictopol.substack.com/p/covid-and-...
Ready for the next #Haemcast? Coming this Thursday, @katekhair.bsky.social looks back on Terence O'Rourke's reflections on life with severe haemophilia and how #haemophilia care has and hasn't changed. https://loom.ly/A4UWu6M
#HemeSky #BloodSky #MedSky #podcast
PSA:
Your period should not
🩸last > 7 days
🩸interfere with your life
🩸happen consistently > than monthly
🩸require product changes more than every 2 hours
🩸have clots larger than a quarter
🩸cause debilitating pain
🩸require double product coverage
🩸make you anemic
You don’t have to suffer.
Happy Birthday 🎂
Fantastic few days in DC with @ash.hematology.org for media training and the Communications committee meeting.
Fabulous people, incredible food, and inspiring discussions on how we can all continue the important work that’s being done.
Figure 1. Pathophysiology of Immune Thrombotic Thrombocytopenic Purpura
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.
Learn more in this Review.
https://ja.ma/4krNDZU
Women affected by #haemophilia often experience delayed diagnosis. This means not having access to the treatment & care they need, impacting quality of life and putting them at risk of serious bleeding. Time to bust the myth that #women don't have haemophilia. #womenbleedtoo
#HemeSky #BloodSky
📚Spotlight on ISTH publications at #ISTH2025:
✅ @rpth.bsky.social: As ISTH’s open-access, online-only journal, RPTH is drives innovation & accessibility in science.
✅ @jthjournal.bsky.social: JTH publishes peer-reviewed groundbreaking research, reviews & clinical guidance
Learn more: bit.ly/4k5PbID
What an inspiring #ISTH2025!
It was wonderful to host the global #thrombosis & #hemostasis community in DC.
From the latest science & innovations to networking & building new collabs - it had it all!
Look out for recordings & other post- @isth.org congress updates.
Goodbye & see you @ #ISTH2026!
Why do we have so little data on pregnancy and thrombotic outcomes in #APS??
Well-illustrated by State-of-the-Art lecture by dr Karen Breen.
We MUST do better!
#ISTH2025
Last day of another fantastic #ISTH2025 #science #innovation #clinicalresearch #thrombosis #hemostasis
Looking forward to #ISTH2026 in Paris
Last day starts with an
Inspiring presentation @rkaczmarekdr.bsky.social #ISTH2025 #hemophilia #genetherapy #Toleranceinduction
Will gene therapy be used for tolerance induction in future?
